ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31366-100mg |
|
1291094-73-9 |
Licogliflozin (LIK066)
|
0 | C23H28O7 | |
GC31366-50mg |
|
1291094-73-9 |
Licogliflozin (LIK066)
|
0 | C23H28O7 | |
GC31366-25mg |
|
1291094-73-9 |
Licogliflozin (LIK066)
|
0 | C23H28O7 | |
GC31366-10mg |
|
1291094-73-9 |
Licogliflozin (LIK066)
|
0 | C23H28O7 | |
GC31366-5mg |
|
1291094-73-9 |
Licogliflozin (LIK066)
|
0 | C23H28O7 | |
GC31366-1mg |
|
1291094-73-9 |
Licogliflozin (LIK066)
|
0 | C23H28O7 | |
GC31366-10mM(1mLinDMSO) |
|
1291094-73-9 |
Licogliflozin (LIK066)
|
0 | C23H28O7 | |
GC31365-1g |
|
11042-64-1 |
γ-Oryzanol
|
0 | C40H58O4 | |
GC31365-10mM(1mLinDMSO) |
|
11042-64-1 |
γ-Oryzanol
|
0 | C40H58O4 | |
GC31364-100mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin)
|
0 | C42H58O6 | |
GC31364-50mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin)
|
0 | C42H58O6 | |
GC31364-25mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin)
|
0 | C42H58O6 | |
GC31364-10mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin)
|
0 | C42H58O6 | |
GC31364-5mg |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin)
|
0 | C42H58O6 | |
GC31364-10mM(1mLinDMSO) |
|
3351-86-8 |
Fucoxanthin (all-trans-Fucoxanthin)
|
0 | C42H58O6 | |
GC31363-100mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1
|
0 | C48H48F2N10O5 | |
GC31363-50mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1
|
0 | C48H48F2N10O5 | |
GC31363-25mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1
|
0 | C48H48F2N10O5 | |
GC31363-10mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1
|
0 | C48H48F2N10O5 | |
GC31363-5mg |
|
2212020-52-3 |
GLP-1 receptor agonist 1
|
0 | C48H48F2N10O5 | |